UCD19 CAR T Cells / University of Colorado 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
UCD19 CAR T Cells / University of Colorado
NCT04544592: UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Recruiting
1/2
50
US
CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
University of Colorado, Denver, National Cancer Institute (NCI)
B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma
06/26
07/26
NCT04240808: Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Active, not recruiting
1
11
US
UCD19 CAR T Cells
University of Colorado, Denver
Non Hodgkin Lymphoma
03/23
12/24
NCT05535855: UCD19 CAR T Therapy in Adults with B-ALL and MRD Positivity in CR1

Recruiting
1
14
US
CD19 Directed CAR T Cell, UCD19 CAR T cells
University of Colorado, Denver
Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia
07/25
07/27

Download Options